# Sex Differences in NMDA-enhancing Treatment of Schizophrenia

> **NCT07122895** · PHASE2 · RECRUITING · sponsor: **China Medical University Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** NMDAE
- **DRUG:** Placebo Cap

## Key facts

- **NCT ID:** NCT07122895
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2029-12
- **Final completion:** 2030-03
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07122895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07122895, "Sex Differences in NMDA-enhancing Treatment of Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07122895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*